| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |